Evidence map›Paper›PMID 35885623›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models.

Mahmoud A F Khalil, Mahmoud R M El-Ansary, Rasha H Bassyouni, Eman E Mahmoud, Inas A Ali, Tarek I Ahmed, Essam A Hassan, Tamer M Samir

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. MultipleFrontiers in cellular and infection microbiology · 2022
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mahmoud A F KhalilDepartment of Microbiology and Immunology, Faculty of Pharmacy, Fayoum University, Fayoum 63514, Egypt.ORCID 0000-0002-9738-1166
Mahmoud R M El-AnsaryDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Misr University for Science and Technology (MUST), Giza 12566, Egypt.ORCID 0000-0003-2458-1930
Rasha H BassyouniDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Fayoum University, Fayoum 63514, Egypt.ORCID 0000-0003-2468-4948
Eman E MahmoudDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Fayoum University, Fayoum 63514, Egypt.
Inas A AliDepartment of Family and Community Medicine, Faculty of Medicine, Misr University for Science and Technology (MUST), Giza 12566, Egypt.
Tarek I AhmedDepartment of Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum 63514, Egypt.
Essam A HassanDepartment of Tropical Medicine, Faculty of Medicine, Fayoum University, Fayoum 63514, Egypt.ORCID 0000-0003-4544-1734
Tamer M SamirDepartment of Microbiology and Immunology, Faculty of Pharmacy, Misr University for Science and Technology (MUST), Giza 12566, Egypt.ORCID 0000-0002-1504-7843
Fayoum University · EGMisr University for Science and Technology · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to investigate the causative species, antifungal susceptibility, and factors associated with oropharyngeal candidiasis (OPC) among Egyptian COVID-19 patients. This is an observational, case-controlled, single-center study that included three groups: COVID-19 patients (30), COVID-19 patients with OPC (39), and healthy individuals (31). Patients' demographic data (age, sex), laboratory tests, comorbidities, treatment, and outcomes were included.

Indexed as

antifungal resistancebiofilmCOVID-19oropharyngeal candidiasisSARS-Cov-2virulence

Identifiers

PMID35885623
PMCPMC9316654
OpenAlexW4285733182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.